Precision BioSciences

Cindy Atwell, Chief Business Officer

Oct. 10 | 3:00pm | Ecolab Life Sciences Ballroom 

Durham, NC


Precision BioSciences, Inc., is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform designed with therapeutic safety, delivery, and control in mind. Using ARCUS, Precision is developing allogeneic CAR T and in vivo gene correction 

By using this website you agree to accept our Privacy Policy and Terms & Conditions